---
title: "TIBET PHARMA released its semi-annual performance report, with a net profit attributable to the parent company of 567 million yuan, a year-on-year decrease of 8.96%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253183138.md"
description: "According to the Zhitong Finance APP, TIBET PHARMA disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.651 billion yuan, a year-on-year increase of 2.23%; the net profit attributable to shareholders of the listed company was 567 million yuan, a year-on-year decrease of 8.96%; the net profit after deducting non-recurring gains and losses was 543 million yuan, a year-on-year increase of 3.69%; the basic earnings per share were 1.76 yuan. The company plans to distribute a cash dividend of 8.81 yuan (tax included) for every 10 shares to all shareholders"
datetime: "2025-08-15T09:32:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253183138.md)
  - [en](https://longbridge.com/en/news/253183138.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253183138.md)
---

# TIBET PHARMA released its semi-annual performance report, with a net profit attributable to the parent company of 567 million yuan, a year-on-year decrease of 8.96%

According to the Zhitong Finance APP, TIBET PHARMA (600211.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.651 billion yuan, a year-on-year increase of 2.23%; the net profit attributable to shareholders of the listed company was 567 million yuan, a year-on-year decrease of 8.96%; the net profit after deducting non-recurring items was 543 million yuan, a year-on-year increase of 3.69%; basic earnings per share were 1.76 yuan. The company plans to distribute a cash dividend of 8.81 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [600211.CN](https://longbridge.com/en/quote/600211.CN.md)

## Related News & Research

- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [12:12 ET117 Partners Exploring Assistance for Potential Anti-Weaponization Fund Claimants](https://longbridge.com/en/news/286943531.md)
- [12:20 ETAmerican Residential Services, LLC. Continues to Expand with the Acquisition of Tipping Hat Plumbing, Heating & Electric](https://longbridge.com/en/news/286944525.md)
- [CertifID Launches New Client Experience to Simplify Real Estate Transactions](https://longbridge.com/en/news/286944337.md)